Dementia risks rise if you suffer from midlife chronic diseases

Credit: Policy Options
Credit: Policy Options

People with two or more chronic conditions (multimorbidity) in midlife had a higher risk of subsequent dementia, a prospective cohort showed.

Midlife multimorbidity more than doubled the risk of dementia later in life, reported Céline Ben Hassen, PhD, of Université de Paris, and colleagues, in The BMJ. Every 5-year younger age at multimorbidity onset upped dementia risk by 18%.

“The specific contribution of this study is to show that early onset of multimorbidity is particularly harmful,” co-author Archana Singh-Manoux, PhD, also of Université de Paris, told MedPage Today.

“Multimorbidity — the occurrence of two or more chronic diseases — is increasingly common and not confined to older ages,” she noted. 

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

“Brain health is likely to be a lifelong process, and the lack of curative solutions for dementia highlights the importance of prevention, starting early in midlife,” Singh-Manoux noted.

“For those with a first chronic condition, it is important to manage the condition so that a second chronic condition is avoided,” she said. “Data from high-income countries show the increasing prevalence of multimorbidity in midlife, and this is likely to have implications for the cognitive status of individuals at older ages.”

This is an excerpt. Read the original post here. 

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jul-26-2026-05_58_17-PM
Louisiana and Texas bring RFK,Jr.- MAHA-backed restrictions on dyes and other ‘controversial’ ingredients to eight states
ChatGPT-Image-Jul-26-2026-05_35_53-PM
FDA takes up peptide therapies as hype outpaces science
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
organic scaled
Facts & Fallacies podcast: Organic food cuts pesticide exposure? A response to Dr. Rhonda Patrick
ChatGPT-Image-Jul-22-2026-09_13_07-AM
Viewpoint—The Strategic Litigation boom: Understanding the tightening coalition among NGOs, foundations, journalists, and tort lawyers
ChatGPT-Image-Jul-9-2026-11_33_49-AM
Viewpoint: High-dose resveratrol supplements to extend health and life? Don’t waste your money.
ChatGPT-Image-Jul-10-2026-09_42_12-AM-1
Peptides, patient autonomy, and the limits of medical freedom
Screenshot-2026-07-23-at-11.58.47-AM
Viewpoint: ‘Thought police in the UK?’ Conservatives lash out at government report calling anti-LGBQT+ narratives ‘false and misleading’
How to Include More Strawberries in Your Diet
Strawberries are berries—and 35 other surprising food and drink myths
IVF Rex
Poll: Younger people more open to using genetics to increase fertility and reduce chances of inherited diseases 
Screenshot-2026-07-07-at-12.55.44-PM
Viewpoint: Yes, we can adapt to a changing climate without devastating the environment and the economy
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-May-22-2026-10_26_09-AM
Trump-RFK, Jr. National Science Board firings: Accountability vs. partisan meddling
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.